Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/12/2003EP1290012A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
03/12/2003EP1290011A1 Melphalan derivatives and their use as cancer chemotherapeutic drugs
03/12/2003EP1290010A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
03/12/2003EP1290007A2 Secreted proteins and polynucleotides encoding them
03/12/2003EP1290005A2 Vegf-modulated genes and methods employing them
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289571A2 Prochelators of radiometal labeled molecules
03/12/2003EP1289568A2 Combination product for carrying out a cytotoxic treatment in a mammal
03/12/2003EP1289567A2 Lyophilizable and enhanced compacted nucleic acids
03/12/2003EP1289565A2 Compounds for targeting endothelial cells
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289553A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
03/12/2003EP1289552A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
03/12/2003EP1289548A2 Immune system stimulating means
03/12/2003EP1289546A1 Combined preparation for the treatment of neoplasic diseases
03/12/2003EP1289544A2 Method for treating a movement disorder
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289542A1 Means for maintenance and/or correction of glucose concentration in blood
03/12/2003EP1289541A2 Interferon for the treatment of multiple sclerosis
03/12/2003EP1289540A2 Methods and compositions for producing a neurosalutary effect in a subject
03/12/2003EP1289539A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289537A2 Method of treating chronic ulcers
03/12/2003EP1289533A1 Whitening compositions containing ascomycete derived enzyme
03/12/2003EP1289532A2 Low carbohydrate compositions, kits thereof, and methods of use
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289529A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
03/12/2003EP1289510A2 Compositions, kits, and methods for promoting defined health benefits
03/12/2003EP1289504A2 Neurotoxin implant
03/12/2003EP1289502A1 Microemulsion preconcentrates, microemulsion and use of such a composition
03/12/2003EP1289501A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289492A1 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals
03/12/2003EP1289472A2 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
03/12/2003EP1289383A1 Primary composition containing a lipophilic bioactive compound
03/12/2003EP1289379A1 Feedstuff additive
03/12/2003EP1223967A4 Fc GAMMA RIA
03/12/2003EP1222199A4 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent
03/12/2003EP1187848A4 Annexin derivatives with endogenous chelation sites
03/12/2003EP1137430B1 Therapeutic agent for the suppression of snoring noises
03/12/2003EP1041967B1 Microparticles and their therapeutic or diagnostic use
03/12/2003EP0979098B1 Method of treating hyperprolactinemia and prolactinomas
03/12/2003EP0946191B1 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity
03/12/2003EP0934064B1 Thrombin inhibitors
03/12/2003EP0907372B1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
03/12/2003EP0895478B1 Component b as cicatrizant
03/12/2003EP0884950B1 A method of killing or inhibiting microbial cells
03/12/2003EP0866870B1 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003EP0831881B1 Cetp for increasing hdl cholesterol level
03/12/2003EP0789577B1 Synthesis of n-substituted oligomers
03/12/2003EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase
03/12/2003EP0781095B1 Cells bearing cd4 decoy receptors and related molecules and methods
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
03/12/2003EP0669973B1 Biological factors and neural stem cells
03/12/2003EP0642301B1 Pharmaceutically acceptable fixed-dried human blood platelets
03/12/2003EP0589930B1 GABA-A RECEPTOR SUBUNITS ($g(a)-2, $g(a)-3, $g(a)-5, $g(a)-6, $g(b)-2) AND TRANSFECTED CELLS EXPRESSING THEM
03/12/2003EP0274482B2 Isolated dna sequences associated with multidrug resistance in human cells
03/12/2003CN1402788A 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity
03/12/2003CN1402784A Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions
03/12/2003CN1402783A Polypeptides and genes encoding same
03/12/2003CN1402782A MAGE-A12 antigenic peptides and uses thereof
03/12/2003CN1402736A 胶原 Collagen
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402706A Antidiabetic agents
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1402643A Integrin-mediated drug targeting
03/12/2003CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
03/12/2003CN1402641A Pharmaceutical compositions of fibrinolytic agent
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1402639A Pharmaceutical combinations
03/12/2003CN1401662A Anticoagulation and thrombolytic thrombus target fusion mA5UKB
03/12/2003CN1401388A Child 'Xuebao' chewing tablet and preparing process thereof
03/12/2003CN1401387A Tumor suppressing polypeptide TSF and gene therapy vector composition
03/12/2003CN1401328A Epidemic meningitis polyose-protein binding vaccine
03/12/2003CN1102854C Composition for sustained release of human growth hormone
03/12/2003CN1102853C Tumor metastasis suppressing agent and veterinary tumor metastasis suppressing agent
03/12/2003CN1102847C Medicine or nutrient contg. daidzein material
03/11/2003USRE38027 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531586 Genetic sequences related to Alzheimer's Disease
03/11/2003US6531584 Nuclease resistant oligonucleotide analogs; DNA or RNA modulation; diagnosis, thearpy of viral diseases
03/11/2003US6531577 High-purity preparations; use in treatment of bleeding disorders
03/11/2003US6531575 Nucleic acid and amino acid sequences relating to title enzyme; use diagnosis, prevention, treatment of cancer, myopathy, neurodegenerative diseases, immune and sympathetic nervous system disorders
03/11/2003US6531573 Histatin-based peptides; amino acid sequences; use treat fungal and bacterial infections in mammals
03/11/2003US6531486 Reacting quinapril or acid addition salt thereof with alkaline magnesium compound in presence of solvent to form quinapril magnesium
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531467 Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
03/11/2003US6531456 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
03/11/2003US6531455 Delivery of polynucleotides by secretory gland expression
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/11/2003US6531451 Isolated antigenic peptide consisting of specified amino acid sequence
03/11/2003US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily
03/11/2003US6531448 Composition comprising protein selected from insulin, insulin analog, and proinsulin; derivatized protein selected from fatty acid-acylated insulins; complexing compound; hexamer stabilizing compound; and divalent metal cation
03/11/2003US6531447 Isolated protein comprising specified amino acid sequence; promotes vascularization
03/11/2003US6531446 Peptides having biological activity
03/11/2003US6531445 Protein-induced morphogenesis in liver tissue
03/11/2003US6531315 Stimulating or expanding T cells (which are specific for cells expressing tumor proteins) by contacting them with given amino acid sequence
03/11/2003US6531314 Growth hormone secretagogue receptor family
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
1 ... 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 ... 3163